Search Results

There are 839293 results for: content related to: The Quadrivalent Human Papillomavirus Vaccine: Potential Factors in Effectiveness

  1. Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis

    Catheterization and Cardiovascular Interventions

    Volume 69, Issue 7, 1 June 2007, Pages: 1064–1074, Tina L. Pinto Slottow and Ron Waksman

    Article first published online : 24 MAY 2007, DOI: 10.1002/ccd.21179

  2. FDA Advisory Panel on the Safety and Efficacy of Drug-Eluting Stents: Summary of Findings and Recommendations

    Journal of Interventional Cardiology


    Article first published online : 27 NOV 2007, DOI: 10.1111/j.1540-8183.2007.00312.x

  3. You have free access to this content
    An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease

    British Journal of Clinical Pharmacology

    Volume 62, Issue 2, August 2006, Pages: 138–152, Mark A. Giembycz

    Article first published online : 2 MAR 2006, DOI: 10.1111/j.1365-2125.2006.02640.x

  4. You have free access to this content
    Perspectives on FDA's Regulation of Nanotechnology: Emerging Challenges and Potential Solutions

    Comprehensive Reviews in Food Science and Food Safety

    Volume 8, Issue 4, October 2009, Pages: 375–393, Brianna (MacDonald) Sandoval

    Article first published online : 16 SEP 2009, DOI: 10.1111/j.1541-4337.2009.00088.x

  5. Race Categorization and the Regulation of Business and Science

    Law & Society Review

    Volume 44, Issue 3-4, September/December 2010, Pages: 617–650, Catherine Lee and John D. Skrentny

    Article first published online : 18 OCT 2010, DOI: 10.1111/j.1540-5893.2010.00418.x

  6. The mantra of blood safety: time for a new tune?

    Vox Sanguinis

    Volume 86, Issue 1, January 2004, Pages: 1–7, A. Farrugia

    Article first published online : 30 JAN 2004, DOI: 10.1111/j.0042-9007.2004.00386.x

  7. Understanding the regulatory hurdles for antibacterial drug development in the post-Ketek world

    Annals of the New York Academy of Sciences

    Volume 1241, Issue 1, December 2011, Pages: 153–161, Roger M. Echols

    Article first published online : 22 DEC 2011, DOI: 10.1111/j.1749-6632.2011.06300.x

  8. You have free access to this content
    A systematic review of the safety of topical therapies for atopic dermatitis

    British Journal of Dermatology

    Volume 156, Issue 2, February 2007, Pages: 203–221, J. Callen, S. Chamlin, L.F. Eichenfield, C. Ellis, M. Girardi, M. Goldfarb, J. Hanifin, P. Lee, D. Margolis, A.S. Paller, D. Piacquadio, W. Peterson, K. Kaulback, M. Fennerty and B.U. Wintroub

    Article first published online : 29 SEP 2006, DOI: 10.1111/j.1365-2133.2006.07538.x

  9. Brief report on the United States Food and Drug Administration Blood Products Advisory Committee recommendations for management of donors and units testing positive for hepatitis B virus DNA

    Vox Sanguinis

    Volume 91, Issue 4, November 2006, Pages: 331–335, C. Lucey

    Article first published online : 18 JUL 2006, DOI: 10.1111/j.1423-0410.2006.00820.x

  10. You have free access to this content
    Steering a course for risk assessment: The impact of new draft guidance, 21 CFR part 11, scope and application, on the electronic records; electronic signatures rule

    The Quality Assurance Journal

    Volume 7, Issue 3, September 2003, Pages: 182–186, George G. Kuniholm

    Article first published online : 29 JUL 2003, DOI: 10.1002/qaj.237

  11. Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling

    Clinical Pharmacology & Therapeutics

    Volume 81, Issue 2, February 2007, Pages: 298–304, S-M Huang, R Temple, D C Throckmorton and L J Lesko

    Article first published online : 27 DEC 2006, DOI: 10.1038/sj.clpt.6100054

  12. Risk of myocardial infarction associated with selective COX-2 inhibitors: Meta-analysis of randomised controlled trials

    Pharmacoepidemiology and Drug Safety

    Volume 16, Issue 7, July 2007, Pages: 762–772, Li-Chia Chen and Darren M Ashcroft

    Article first published online : 25 APR 2007, DOI: 10.1002/pds.1409

  13. You have free access to this content
    The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors

    Arthritis Care & Research

    Volume 47, Issue 4, 15 August 2002, Pages: 349–355, Vibeke Strand and Marc C. Hochberg

    Article first published online : 12 AUG 2002, DOI: 10.1002/art.10560

  14. Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials

    Journal of Clinical Pharmacy and Therapeutics

    Volume 31, Issue 6, December 2006, Pages: 565–576, L-C. Chen and D. M. Ashcroft

    Article first published online : 24 NOV 2006, DOI: 10.1111/j.1365-2710.2006.00774.x

  15. Label development and the label comprehension study for over-the-counter drugs

    Clinical Pharmacology & Therapeutics

    Volume 74, Issue 5, November 2003, Pages: 406–412, Eric P. Brass and Michael Weintraub

    Article first published online : 27 NOV 2003, DOI: 10.1016/S0009-9236(03)00239-X

  16. You have free access to this content
    Prescriptions for Chronic High-Dose Cyclooxygenase-2 Inhibitors are Often Inappropriate and Potentially Dangerous

    Journal of General Internal Medicine

    Volume 20, Issue 10, October 2005, Pages: 879–883, Christianne L. Roumie, Patrick G. Arbogast, Edward F. Mitchel Jr. and Marie R. Griffin

    Article first published online : 14 JUL 2005, DOI: 10.1111/j.1525-1497.2005.0173.x

  17. You have free access to this content
    Pacing Techniques in Heart Failure: Current Concepts and Future Outlook

    Congestive Heart Failure

    Volume 9, Issue 4, July/August 2003, Pages: 214–229, Freddy M. Abi-Samra

    Article first published online : 8 JUN 2007, DOI: 10.1111/j.1527-5299.2003.01464.x

  18. Pharmacovigilance-related topics at the level of the International Conference on Harmonisation (ICH)

    Pharmacoepidemiology and Drug Safety

    Volume 14, Issue 6, June 2005, Pages: 377–387, Priya Bahri and Panos Tsintis

    Article first published online : 1 NOV 2004, DOI: 10.1002/pds.1043

  19. You have free access to this content
    Selective cyclooxygenase 2 inhibitors and cardiovascular events

    Arthritis & Rheumatism

    Volume 52, Issue 7, July 2005, Pages: 1968–1978, Daniel H. Solomon

    Article first published online : 28 JUN 2005, DOI: 10.1002/art.21132

  20. Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with men


    Volume 49, Issue 6, June 2009, Pages: 1102–1114, Steven A. Anderson, Hong Yang, Lou M. Gallagher, Sharon O'Callaghan, Richard A. Forshee, Michael P. Busch, Matthew T. McKenna, Ian Williams, Alan Williams, Matthew J. Kuehnert, Susan Stramer, Steve Kleinman, Jay Epstein and Andrew I. Dayton

    Article first published online : 20 MAR 2009, DOI: 10.1111/j.1537-2995.2009.02124.x